Real-world effectiveness of tildrakizumab in a Phase 4 study in patients with moderate-to- severe plaque psoriasis

被引：0
|
作者：
Bhatia, Neal [1 ]
Vasquez, J. Gabriel [2 ]
Schenkel, Brad
Rozzo, Stephen J. [3 ]
Heim, Jayme [2 ]
机构：
[1] Therapeut Clin Res, San Diego, CA USA
[2] West Michigan Dermatol, Grandville, MI USA
[3] Sun Pharmaceut Ind Inc, Princeton, NJ USA
来源：
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2023年 / 89卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：AB216 / AB216
页数：1
相关论文
共 50 条
  • [11] Improvements in Psoriasis-Related Work Productivity with Tildrakizumab: Results from a Phase 4 Real-World Study in Patients with Moderate-to-Severe Plaque Psoriasis
    Bhutani, Tina
    Koo, John
    Heim, Jayme
    Bhatia, Neal
    Mathew, Jacob
    Ferro, Thomas
    Vasquez, J. Gabriel
    [J]. DERMATOLOGY AND THERAPY, 2024, 14 (04) : 1019 - 1025
  • [12] A Phase 4, real-world study of tildrakizumab in moderate to severe psoriasis: Week 28 interim analysis
    Heim, Jayme
    Vasquez, J. Gabriel
    Beute, Paulita
    Torres, Monique
    Rozzo, Stephen J.
    Bhatia, Neal
    [J]. AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2022, 63 : 6 - 6
  • [13] A phase 4, real-world study of tildrakizumab in moderate to severe psoriasis: Week 28 interim analysis
    Heim, Jayme
    Vasquez, J. Gabriel
    Beute, Paulita
    Torres, Monique
    Rozzo, Stephen J.
    Bhatia, Neal
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2022, 87 (03) : AB132 - AB132
  • [14] Long-term quality of life outcomes from a phase 4 study of tildrakizumab in patients with moderate-to-severe plaque psoriasis in a real-world setting
    Bhatia, Neal
    Heim, Jayme
    Vasquez, J. Gabriel
    Bhutani, Tina
    Schenkel, Brad
    Gogineni, Ranga
    Koo, John
    [J]. JOURNAL OF DERMATOLOGICAL TREATMENT, 2024, 35 (01)
  • [15] Effectiveness and safety of secukinumab in Chinese patients with moderate to severe plaque psoriasis in real-world practice
    Zhou, Jian
    Yuan, Yuan
    Liu, Yanhua
    Chu, Mengyang
    Liu, Huan
    Liu, Qian
    Wang, Rui
    Shao, Shuai
    Wang, Gang
    Yu, Chen
    [J]. EXPERIMENTAL DERMATOLOGY, 2024, 33 (01)
  • [16] Real-world data on the effectiveness of brodalumab in patients with moderate-to severe plaque psoriasis in the Greek clinical setting (the BrIDGE study)
    Rigopoulos, Dimitrios
    Tampouratzi, Eleftheria
    Angelakopoulos, Charalampos
    Apalla, Zoe
    Barkis, Ioannis
    Georgiou, Sophia
    Delli, Florentina
    Drosos, Alexandros
    Zafiriou, Efterpi
    Katsantonis, John
    Lazaridou, Elisavet
    Panagakis, Pantelis
    Papadavid, Evangelia
    Papakonstantis, Markos
    Roussaki-Schulze, Angeliki-Viktoria
    Sotiriou, Elena
    Anastasiadis, Georgios
    Chasapi, Vasiliki
    Sfaelos, Konstantinos
    Ioannides, Dimitrios
    [J]. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2024, 38 (06) : 1121 - 1130
  • [17] Quality of life and patient-reported symptoms in a Phase 4, real-world study of tildrakizumab in patients with moderate-to-severe psoriasis: Week 28 interim analysis
    Bhatia, Neal
    Heim, Jayme
    Schenkel, Brad
    Vasquez, J. Gabriel
    [J]. JOURNAL OF DERMATOLOGICAL TREATMENT, 2023, 34 (01)
  • [18] Tildrakizumab in moderate-to-severe plaque psoriasis: A multicenter, retrospective, real-life study
    Caldarola, Giacomo
    Galluzzo, Marco
    Bernardini, Nicoletta
    Calabrese, Laura
    Grimaldi, Marta
    Moretta, Gaia
    Pagnanelli, Gianluca
    Shumak, Ruslana Gaeta
    Talamonti, Marina
    Tofani, Lorenzo
    Pallotta, Sabatino
    Peris, Ketty
    Potenza, Concetta
    De Simone, Clara
    Campione, Elena
    [J]. DERMATOLOGIC THERAPY, 2022, 35 (06)
  • [19] Tildrakizumab for the treatment of moderate-to-severe psoriasis: a 52-week, real-world Portuguese multicentric study
    Torres, Tiago
    Varela, Paulo
    Bastos, Pedro Mendes
    Magina, Sofia
    Henrique, Martinha
    Ferreira, Paulo
    [J]. DRUGS IN CONTEXT, 2024, 13
  • [20] Tildrakizumab: A Review in Moderate-to-Severe Plaque Psoriasis
    Frampton, James E.
    [J]. AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, 2019, 20 (02) : 295 - 306
12345